Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
4(100.0%)
4Total
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01966965Phase 3Unknown

Efficacy and Safety Study for PIOLIN® Shampoo

Role: lead

NCT01485328Phase 3Completed

Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

Role: collaborator

NCT01365676Phase 3Unknown

GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms

Role: lead

NCT01283568Unknown

Safety and Efficacy Study of Gamaline+Hipericin in PMS

Role: lead

NCT01481025Phase 3Unknown

Efficacy and Safety for Cimicifuga/Hypericum Product

Role: lead

All 5 trials loaded